For instance, the previously study confirmed that TAB3 is a downstream effector of TGFβ pathway [18], and TGFβ pathway has been demonstrated to be involved in the chemoresistance of CRC [34, 35]. This evidence concerns the gene TAB3 and colorectal carcinoma.